Investor Relations

Third Quarter 2021 Business Update Conference Call
Nov 23, 2021 4:30 pm EST
Toll Free dial-In Number: 1-877-407-0789
Toll/International dial-in number: 1-201-689-8562
Conference ID: 13725189
Webcast Presentation

Corporate Videos

The Future of Innovation In Pharmaceutical Oral Delivery Systems

Innovation As a Differentiation in Technology, Products and Culture

Company Overview

Procaps Group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have direct presence in 13 countries in Latin America and we have more than 5,000 collaborators working under a sustainable model.

We develop, manufacture, and market over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potential clinical solutions.

Investor Contact Information

Company

Procaps Group
9 Rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

MZ Group – MZ North America
Chris Tyson
Executive Vice President
T: (949) 491-8235
PROC@mzgroup.us
https://www.mzgroup.us

Procaps Group Company Contact
Maria Alejandra Molina
Legal Compliance Director
T: (57)(5) 3719162)
mamolina@procaps.com.co